AEGiS-UPI: Study could revolutionize AIDS research United Press InternationalImportant note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.
Click here to return to United Press International main menu
DonateNow
Print this article




Study could revolutionize AIDS research

United Press International - October 11, 2006


NEW YORK - U.S. scientists have created a version of HIV that replicates in human and monkey cells -- an advance that might revolutionize AIDS research.

Rockefeller University and Aaron Diamond AIDS Research Center scientists say they used a combination of genetic engineering and forced adaptation in the study.

Since HIV-1 viruses won't replicate in monkey cells, researchers use monkey virus to test potential therapies and vaccines in animals. But therapies and vaccines that are effective on simian immunodeficiency virus don't necessarily translate into human success.

Now Paul Bieniasz, head of the university's Laboratory of Retrovirology, describes how he and colleagues replaced just a few parts of the human virus -- the ones responsible for blocking replication in monkey cells -- with components from SIV.

"Overall, the virus is a mixture of engineering and forced evolution," Bieniasz and the paper's first author, research assistant Theodora Hatziioannou, said. "It sounds simple, in theory, but it took us two years to do. If we can make this virus work in animals the way it works in tissue culture, it will likely change the way AIDS vaccine and therapeutics research is done."

The research appears in the journal Science.


061011
UP061007


Copyright © 2006 - United Press International. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through United Press International, Permissions Desk, 1510 H St. N.W. Washington DC 2005. Main Phone Switchboard: 202-898-8000 FAX: 202-898-8057 or 202-898-8147 Email: info@upi.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .